SCOPUS 정보 검색 플랫폼

Actas Dermo-Sifiliograficas

Volumn 100, Issue SUPPL. 1, 2009, Pages 86-91

Challenges encountered in dermatologic drug development

(3) Eaglstein, W H a,c Cash, K R b Corcoran, G R b

a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE (United States)

b Stiefel aGSK Company (United States)

c NONE

Author keywords

Dermatologic treatments; Economic potential; Investment

Indexed keywords

ACANYA; ADAPALENE; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ATORVASTATIN; BENZACLIN; BENZOYL PEROXIDE; BETAMETHASONE; BETAMETHASONE DIPROPIONATE; BETAMETHASONE DIPROPIONATE PLUS CALCIPOTRIOL; CALCIPOTRIOL; CLINDAMYCIN; CLINDAMYCIN PHOSPHATE; CLOPIDOGREL; DUAC; EMULSIFYING AGENT; EPIDUO; ETANERCEPT; FLUOCINOLONE ACETONIDE; HYDROQUINONE; IMIQUIMOD; INFLIXIMAB; ISOTRETINOIN; PRESERVATIVE; RECOMBINANT ERYTHROPOIETIN; RETINOIC ACID; RITUXIMAB; ROFECOXIB; TACLONEX; TRILUMA; UNCLASSIFIED DRUG; ZIANA;

ACNE; ANEMIA; CARCINOGENICITY; CONTACT ALLERGY; DRUG COST; DRUG INDUSTRY; DRUG MARKETING; DRUG PENETRATION; DRUG RESEARCH; DRUG STABILITY; ECONOMIC ASPECT; HUMAN; NONHODGKIN LYMPHOMA; NONHUMAN; PATHOPHYSIOLOGY; PHOTOALLERGY; QUANTITATIVE ANALYSIS; REVIEW; RISK FACTOR; SHELF LIFE; SKIN DISEASE;

EID: 75449118546 PISSN: 00017310 EISSN: 15782190 Source Type: Journal
DOI: 10.1016/S0001-7310(09)73172-2 Document Type: Article

Times cited : (4)

References (12)

1
- 0037374498
- The Price of Innovation: New Estimates of Drug Development Costs
- J.A. DiMasi, R.W. Hansen, and H.G. Grabowski The Price of Innovation: New Estimates of Drug Development Costs J Health Economics 22 2003 151 185
- (2003) J Health Economics , vol.22 , pp. 151-185
- DiMasi, J.A.¹ Hansen, R.W.² Grabowski, H.G.³

2
- 75449096012
- Med Ad News. 2008.
- (2008) Med Ad News

3
- 75449091325
- November
- The Wall Street Journal. November; 2005.
- (2005) The Wall Street Journal

4
- 75449090397
- IMS Health Data; 2008.
- (2008) IMS Health Data

5
- 75449092370
- Graceway Pharmaceuticals, LLC. Bristol, TN. Revised-April
- Aldara® (imiquimod) Cream, 5% [prescribing information], Graceway Pharmaceuticals, LLC. Bristol, TN. Revised-April 2009.
- (2009) Aldara® (Imiquimod) Cream, 5% [Prescribing Information]

6
- 75449117049
- Dermik Laboratories, a business of Sanofi-Aventis U.S. LLC. Bridgewater, NJ © 2009.
- BenzaClin® (clindamycin 1%, benzoyl peroxide 5%) Topical Gel [prescribing information]. Dermik Laboratories, a business of Sanofi-Aventis U.S. LLC. Bridgewater, NJ © 2009.
- BenzaClin® (Clindamycin 1%, Benzoyl Peroxide 5%) Topical Gel [Prescribing Information]

7
- 75449116062
- Roche Laboratories, Inc., Nutley, NJ. Revised November
- Accutane (isotretinoin) capsules [prescribing information]. Roche Laboratories, Inc., Nutley, NJ. Revised November 2008.
- (2008) Accutane (Isotretinoin) Capsules [Prescribing Information]

8
- 75449120039
- MIDAS, IMS Health, 2008.
- (2008) MIDAS, IMS Health

9
- 75449090397
- IMS Health Data; 2008
- (2008) IMS Health Data

10
- 84941818257
- Method for comparing percutaneous absorption of steroids
- A.W. Mackenzie Method for comparing percutaneous absorption of steroids Arch Dermatol 86 1964 608 610
- (1964) Arch Dermatol , vol.86 , pp. 608-610
- MacKenzie, A.W.¹

11
- 47149114761
- Determining bioequivalence of topical dermatological drug products by tape-stripping
- W. Navidi, A. Hutchinson, B. N'Dri-Stempfer, and A. Bunge Determining bioequivalence of topical dermatological drug products by tape-stripping J Pharmacokinet Pharmacodyn 35 2008 337 348
- (2008) J Pharmacokinet Pharmacodyn , vol.35 , pp. 337-348
- Navidi, W.¹ Hutchinson, A.² N'Dri-Stempfer, B.³ Bunge, A.⁴

12
- 75449096721
- World Pharma Network
- B. Hughes-Formella, and D. Bucks Topical drug development: Formulation through Preclinic 2007 World Pharma Network
- (2007) Topical Drug Development: Formulation Through Preclinic
- Hughes-Formella, B.¹ Bucks, D.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.